Gavura S

ORCID: 0000-0002-8635-6889 · 1 paper in corpus
2024
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol31060264

Niraparib was recently funded in Canada for the maintenance treatment of ovarian cancer following platinum-based chemotherapy. However, the drug's safety profile in the real world remains uncertain. We conducted a cohort study to describe t…